Featuring an interview with Dr Eytan Stein, including the following topics:
- Practical considerations for using venetoclax/HMA (hypomethylating agent) combinations in the management of acute myeloid leukemia (AML) (0:00)
- Approach to transplant for older patients with AML (10:33)
- Potential availability of magrolimab and sabatolimab in clinical practice (13:04)
- ASH 2022 preview: Investigational therapies excluding transplantation and cellular immunotherapies (17:33)
- Activity, tolerability and future directions with FLT3 and IDH inhibitors in AML (22:29)
CME information and select publications
Research To Practice | Oncology Videos